Smith & Nephew Share Price (SN.)

Show Chart Filters
Time period:
Moving Average:
Compare to:
Price 1,654.50on 15-11-2019 at 16:30:00
Change -1.00 -0.06%
Buy 1,656.50
Sell 1,655.50
Buy / Sell SN. Shares
Sponsored Financial Content
Last Trade: Sell 3,600 at 1,654.50p
Day's Volume: 1,695,551
Last Close: 1,655.50p
Open: 1,661.00p
ISIN: GB0009223206
Day's Range 1,653.00p - 1,671.00p
52wk Range: 1,376.00p - 1,998.00p
Market Capitalisation: £14,525m
VWAP: 0.00p
Shares in Issue: 876m

Recent Trades History Smith & Nephew (SN.)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell*3,6001,654.50Ordinary
Delayed publication
17:23:43 - 15-Nov-19
Sell*3,6001,654.50Ordinary
Delayed publication
17:23:43 - 15-Nov-19
Sell*2171,654.50Ordinary
Delayed publication
17:36:06 - 15-Nov-19
Sell*2341,654.50Ordinary
Delayed publication
17:21:44 - 15-Nov-19
Buy*2491,663.861Ordinary
17:46:26 - 15-Nov-19
Buy*3051,658.709Ordinary
17:43:09 - 15-Nov-19
Sell*321,654.50Ordinary
17:36:06 - 15-Nov-19
Buy*2,3321,658.719Ordinary
17:36:31 - 15-Nov-19
Buy*2,7141,658.709Ordinary
17:36:12 - 15-Nov-19
Sell*6,9191,654.50Ordinary
17:19:20 - 15-Nov-19

Share Price History for Smith & Nephew

Time period:
to
Date Open High Low Close
14th Nov 2019 (Thu)1,662.001,684.001,647.001,659.00
13th Nov 2019 (Wed)1,635.501,669.501,629.001,668.50
12th Nov 2019 (Tue)1,630.501,644.501,626.001,629.00
11th Nov 2019 (Mon)1,647.501,659.501,614.001,636.00
8th Nov 2019 (Fri)1,659.501,671.501,648.001,655.50
7th Nov 2019 (Thu)1,669.001,675.001,658.501,660.50
6th Nov 2019 (Wed)1,656.001,661.001,642.001,658.50
5th Nov 2019 (Tue)1,665.501,667.501,649.001,656.00
4th Nov 2019 (Mon)1,655.001,669.001,642.501,661.75
1st Nov 2019 (Fri)1,658.501,675.501,651.001,660.00
31st Oct 2019 (Thu)1,714.001,742.001,634.501,647.25
30th Oct 2019 (Wed)1,691.501,720.501,691.501,717.75
29th Oct 2019 (Tue)1,690.001,692.001,671.001,692.25
28th Oct 2019 (Mon)1,691.501,700.001,676.001,692.25
25th Oct 2019 (Fri)1,694.501,707.501,688.001,689.00
24th Oct 2019 (Thu)1,671.001,706.501,666.001,703.00
23rd Oct 2019 (Wed)1,672.001,692.001,661.501,673.50
22nd Oct 2019 (Tue)1,663.501,702.501,655.501,693.00
21st Oct 2019 (Mon)1,780.001,780.501,648.501,676.50
18th Oct 2019 (Fri)1,833.001,849.501,821.001,833.75
17th Oct 2019 (Thu)1,849.501,854.001,829.001,848.75
16th Oct 2019 (Wed)1,841.001,859.001,819.001,830.25

SN. - Smith & Nephew Investor Summary

Smith & Nephew are presently the UK's largest medical technology company and one of global significance in its specialised field. Established over 150 years ago, the company now operates in over 30 countries worldwide, with their headquarters still being in London, UK. Their main focus revolves around developing and promoting novel products to help physicians treat aging patients with endoscopy techniques, orthopaedic reconstruction, trauma and advanced wound management being at the forefront of their research. The company feel that the increasingly aging population equals a significant growth potential for the already established markets of orthopaedics, endoscopy and wound management around the world.

Today, Smith & Nephew have over 1000 products in their arsenal and generate worldwide sales of over 3.4 billion dollars. They further report that over the last 5 years their revenues have grown from around nineteen hundred million dollars to over thirty three hundred million dollars – a percentage increase of nearly 100%. This success has been helped along by the launch of a new range of ingenious wound dressing products in 2008 and the acquisition of the Swiss company Plus Orthopaedics Holdings AG in 2007. Smith & Nephew research, develop and manufacture a number of new orthopaedic and wound management products each year, many of which quickly become established products within the UK and the US. The share price of this major medtech company has stayed stable for a number of years and continues to rise as new products are launched.

News about Smith & Nephew (SN.)

Broker Forecast - Goldman Sachs issues a broker note on Smith & Nephew PLC

News - Wednesday, November 13, 2019

Goldman Sachs today reaffirms its neutral investment rating on Smith & Nephe......

Broker Forecast - Credit Suisse issues a broker note on Smith & Nephew PLC

News - Monday, November 04, 2019

Credit Suisse today reaffirms its neutral investment rating on Smith & Nephe......

FTSE 100 Latest
Value7,302.94
Change10.18


Login to your account

Forgot Password?

Not Registered